Loading chat...
CA SB607
Bill
Status
Passed
9/28/2024
Primary Sponsor
Anthony Portantino
Click for details
AI Summary
- Extends opioid prescription discussion requirements from minors only to all patients before prescribers dispense or issue the first prescription for a controlled substance containing an opioid in a single course of treatment
- Requires prescribers to discuss risks of addiction and overdose, increased addiction risk for individuals with mental health and substance abuse disorders, dangers of mixing opioids with benzodiazepines/alcohol/central nervous system depressants, and any other legally required information
- Exempts discussions in emergency services, emergency surgery (inpatient or outpatient), or when prescriber determines the discussion would be detrimental to patient health, safety, or confidentiality rights
- Specifies that failure to comply with discussion requirements does not constitute a criminal offense
- Approved by Governor on September 28, 2024
Legislative Description
Controlled substances.
Last Action
Chaptered by Secretary of State. Chapter 862, Statutes of 2024.
9/28/2024
Committee Referrals
Appropriations6/11/2024
Business and Professions4/29/2024
Appropriations1/8/2024
Business, Professions and Economic Development1/3/2024
Rules1/3/2024
Health2/22/2023
Rules2/15/2023
Full Bill Text
No bill text available